With over 380,000 people now affected by GH in the UK, and the condition being greatly undiagnosed (80-90%) the training is a must for clinicians working in any part of the UK. GH treatment is simple, clinically-effective and cheap. Left untreated, people with GH can experience liver disease, cancers, heart problems, diabetes, chronic fatigue and acute joint pain.

Following the British Society of Haematology Guidelines each training session provide in-depth coverage of genetic haemochromatosis (GH). 

This one-hour webinar is for primary care practitioners, including GPs and practice managers. It covers the following aspects of genetic haemochromatosis (GH) :

  • An introduction to GH, including the latest prevalence statistics
  • The key gene mutations that lead to GH  
  • How to identify early, classic and late-stage GH symptoms in patients
  • The impact of later symptoms in regards to patients and NHS resources
  • How to support the GH patient care pathways and when to refer to secondary care
  • The ongoing management and treatment for a patient with GH
  • When family screening and genetic counselling should be performed.

Pre-registration via this link is essential.